Singapore markets closed

Precision BioSciences, Inc. (DTIL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.3413-0.0148 (-4.16%)
At close: 04:00PM EDT
0.3431 +0.00 (+0.53%)
After hours: 07:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 39.27M
Enterprise value -70.53M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.82
Price/book (mrq)1.15
Enterprise value/revenue -1.52
Enterprise value/EBITDA 0.90

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 3-75.64%
S&P500 52-week change 316.57%
52-week high 31.7000
52-week low 30.3410
50-day moving average 30.4838
200-day moving average 30.8095

Share statistics

Avg vol (3-month) 31.09M
Avg vol (10-day) 3662.23k
Shares outstanding 5115.07M
Implied shares outstanding 6115.07M
Float 882.53M
% held by insiders 114.90%
% held by institutions 143.77%
Shares short (14 Sept 2023) 41.58M
Short ratio (14 Sept 2023) 40.94
Short % of float (14 Sept 2023) 41.58%
Short % of shares outstanding (14 Sept 2023) 41.37%
Shares short (prior month 14 Aug 2023) 41.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin -192.10%
Operating margin (ttm)-171.78%

Management effectiveness

Return on assets (ttm)-20.86%
Return on equity (ttm)-130.43%

Income statement

Revenue (ttm)46.53M
Revenue per share (ttm)0.41
Quarterly revenue growth (yoy)418.00%
Gross profit (ttm)25.1M
EBITDA -72.11M
Net income avi to common (ttm)-89.39M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)137.79M
Total cash per share (mrq)1.2
Total debt (mrq)27.99M
Total debt/equity (mrq)82.22%
Current ratio (mrq)2.62
Book value per share (mrq)0.30

Cash flow statement

Operating cash flow (ttm)-45.26M
Levered free cash flow (ttm)5.14M